Overview
This book explores recent advances in the application of cell culture for experimental and clinical use. It addresses fundamental issues such as cell line misidentification and offers practical tips for its prevention. It also highlights the latest trends in human cell research for establishing disease models, drug discovery, and new therapeutic trials. The chapters provide a comprehensive guide to the establishment, maintenance, and passage methods of established cell lines, based on the history of cell line establishment. The book also details research activities and effective examples of clinical use of these established cell lines. In particular, dental pulp-derived stem cells are utilized as an example of primary culture, highlighting important perspectives in establishing clinical-grade standards for regenerative therapy and personalized medicine. It also covers innovative culture techniques of respiratory epithelial cells and their application to clinical studies. The book addresses the issue of cell line misidentification and clarifies the methods for determining the correct cell lines. Recent efforts to isolate and culture cells from trace amounts of clinical samples are also discussed, offering technical insights and outlining challenges for future applications of circulating tumor cells. Furthermore, it provides an overview of organoid culture and its applications in cancer research. The latter part of the book focuses on limitations of long-established cell lines suffering from genomic drift, a lack of clinical annotation, and the underrepresentation of rare cancers. Also, it describes the critical role of cancer cell lines in advancing rare-cancer research. The final chapter introduces research examples using iPS cells and AI in the field of neurodegenerative diseases, focusing on reprogramming technology. This book is intended for researchers, clinicians and students in the fields of cancer research, cell physiology, drug discovery and stem/iPS cell research.
Full Product Details
Author: Nariyoshi Shinomiya ,
Yutaka Shimada
Publisher: Springer
Imprint: Springer
ISBN: 9789819505869
ISBN 10: 9819505860
Pages: 169
Publication Date: 13 October 2025
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Hardback
Publisher's Status: Forthcoming
Availability: Not yet available
This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release.
Author Information
Nariyoshi SHINOMIYA, M.D., Ph.D., was a professor and the president of the National Defense Medical College (NDMC) until 2024. Currently, he is Professor Emeritus at the NDMC and a visiting senior researcher at the National Institute of Infectious Diseases, Japan Institute for Health Security. His areas of expertise are microbiology/immunology and molecular oncology. His research interests include radiosensitivity and apoptosis of tumor cells, Met tyrosine kinase function and regulation of tumor growth, etc. He served as President of the Japan Human Cell Society from 2015 to 2023. Yutaka SHIMADA, M.D., Ph.D., FACS, has been a professor at the Department of Nanobio Drug Discovery at Kyoto University. He established more than 60 human esophageal cancer cell lines (KYSE-series) and 10 pancreatic cancer cell lines (KMP-series, TYPK-series). He has also established several gallbladder and bile duct cancer cell lines. His recent research focuses on establishing a standard method for culturing circulating tumor cells. He served as Vice President of the Japan Human Cell Society from 2015 to 2023.
